Insmed Incorporated
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Trade Insmed Incorporated 24 hours a day, five days a week on Robinhood.
Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.About INSM
Insmed, Inc. is a global biopharmaceutical company, which engages in the development and commercialization of therapies for patients with rare diseases. Its focuses on Brensocatib, and Treprostinil Palmitil Inhalation Powder (TPIP) pipeline.
CEOWilliam H. Lewis
CEOWilliam H. Lewis
Employees1,271
Employees1,271
HeadquartersBridgewater, New Jersey
HeadquartersBridgewater, New Jersey
Founded1988
Founded1988
Employees1,271
Employees1,271
INSM Key Statistics
Market cap12.11B
Market cap12.11B
Price-Earnings ratio-11.39
Price-Earnings ratio-11.39
Dividend yield—
Dividend yield—
Average volume2.16M
Average volume2.16M
High today$68.35
High today$68.35
Low today$66.03
Low today$66.03
Open price$67.81
Open price$67.81
Volume952.21K
Volume952.21K
52 Week high$84.91
52 Week high$84.91
52 Week low$21.92
52 Week low$21.92
INSM News
Benzinga 5h
This Insmed Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For TuesdayTop Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiat...
TipRanks 1d
Insmed’s Promising Financial Performance and Pipeline Developments Drive Buy RatingJoseph Schwartz, an analyst from Leerink Partners, reiterated the Buy rating on Insmed (INSM – Research Report). The associated price target remains the same wi...
TipRanks 1d
Insmed’s Growth Potential: Catalysts and Strategic Developments Supporting a Buy RatingAndrew Fein, an analyst from H.C. Wainwright, reiterated the Buy rating on Insmed (INSM – Research Report). The associated price target remains the same with $9...
Analyst ratings
100%
of 19 ratingsBuy
100%
Hold
0%
Sell
0%
People also own
Based on the portfolios of people who own INSM. This list is generated using Robinhood data, and it’s not a recommendation.